{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:32:24Z","timestamp":1788885144038,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09794-x","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:19:01Z","timestamp":1721722741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB"],"prefix":"10.1007","volume":"51","author":[{"given":"Hiba Hussein A.","family":"Khair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u015f\u0131k Didem","family":"Karag\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"issue":"1","key":"9794_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Ca Cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"Ca Cancer J Clin"},{"issue":"8","key":"9794_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong K-K (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer 14(8):535\u2013546. https:\/\/doi.org\/10.1038\/nrc3775","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"9794_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409\u2013436. https:\/\/doi.org\/10.3322\/caac.21731","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"9794_CR4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/cancers14071759","volume":"14","author":"L Seguin","year":"2022","unstructured":"Seguin L, Durandy M, Feral CC (2022) Lung adenocarcinoma tumor origin: a guide for personalized medicine. Cancers (Basel) 14(7):1759. https:\/\/doi.org\/10.3390\/cancers14071759","journal-title":"Cancers (Basel)"},{"issue":"3","key":"9794_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"9794_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RYJ, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"issue":"10","key":"9794_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14(10):611\u2013629. https:\/\/doi.org\/10.1038\/nrclinonc.2017.44","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"9794_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial\u2013mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131\u2013142. https:\/\/doi.org\/10.1038\/nrm1835","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"9794_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20(2):69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"15","key":"9794_CR10","doi-asserted-by":"publisher","first-page":"12412","DOI":"10.3390\/ijms241512412","volume":"24","author":"A Mottais","year":"2023","unstructured":"Mottais A, Riberi L, Falco A, Soccal S, Gohy S, De Rose V (2023) Epithelial\u2013mesenchymal transition mechanisms in Chronic Airway diseases: a common process to target? Int J Mol Sci 24(15):12412. https:\/\/doi.org\/10.3390\/ijms241512412","journal-title":"Int J Mol Sci"},{"issue":"9","key":"9794_CR11","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/biom11091394","volume":"11","author":"MQ Mahmood","year":"2021","unstructured":"Mahmood MQ, Shukla SD, Ward C, Walters EH (2021) The underappreciated role of epithelial mesenchymal transition in chronic obstructive pulmonary disease and its strong link to lung cancer. Biomolecules 11(9):1394. https:\/\/doi.org\/10.3390\/biom11091394","journal-title":"Biomolecules"},{"issue":"7","key":"9794_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522\u2013531. https:\/\/doi.org\/10.1038\/nrg1379","journal-title":"Nat Rev Genet"},{"issue":"11","key":"9794_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857\u2013866. https:\/\/doi.org\/10.1038\/nrc1997","journal-title":"Nat Rev Cancer"},{"key":"9794_CR14","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s00018-018-2877-x","volume":"75","author":"C Bica-Pop","year":"2018","unstructured":"Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I (2018) Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci 75:3539\u20133551. https:\/\/doi.org\/10.1007\/s00018-018-2877-x","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"9794_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","volume":"18","author":"ME Hatley","year":"2010","unstructured":"Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E et al (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18(3):282\u2013293. https:\/\/doi.org\/10.1016\/j.ccr.2010.08.013","journal-title":"Cancer Cell"},{"key":"9794_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-012-1443-3","volume":"372","author":"Z-L Liu","year":"2013","unstructured":"Liu Z-L, Wang H, Liu J, Wang Z-X (2013) MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo-or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372:35\u201345. https:\/\/doi.org\/10.1007\/s11010-012-1443-3","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"9794_CR17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1159\/000488831","volume":"46","author":"B Zhou","year":"2018","unstructured":"Zhou B, Wang D, Sun G, Mei F, Cui Y, Xu H (2018) Effect of miR-21 on apoptosis in lung cancer cell through inhibiting the PI3K\/Akt\/NF-\u03baB signaling pathway in vitro and in vivo. Cell Physiol Biochem 46(3):999\u20131008. https:\/\/doi.org\/10.1159\/000488831","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"9794_CR18","first-page":"692","volume":"13","author":"H Li","year":"2020","unstructured":"Li H, Zhao J, Jia X, Zhang Y, Du Y, Li H et al (2020) miR-21 promotes growth, invasion and migration of lung cancer cells by AKT\/P-AKT\/cleaved-caspase 3\/MMP-2\/MMP-9 signaling pathway. Int J Clin Exp Pathol 13(4):692","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"9794_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1541-7786.MCR-09-0465","volume":"8","author":"EC Connolly","year":"2010","unstructured":"Connolly EC, Van Doorslaer K, Rogler LE, Rogler CE (2010) Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol cancer Res 8(5):691\u2013700. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0465","journal-title":"Mol cancer Res"},{"issue":"2","key":"9794_CR20","doi-asserted-by":"publisher","first-page":"e16979","DOI":"10.1371\/journal.pone.0016979","volume":"6","author":"C Sabatel","year":"2011","unstructured":"Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez M-LA et al (2011) MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS ONE 6(2):e16979. https:\/\/doi.org\/10.1371\/journal.pone.0016979","journal-title":"PLoS ONE"},{"issue":"19","key":"9794_CR21","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.febslet.2011.08.014","volume":"585","author":"M Liu","year":"2011","unstructured":"Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng Y et al (2011) miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett 585(19):2998\u20133005. https:\/\/doi.org\/10.1016\/j.febslet.2011.08.014","journal-title":"FEBS Lett"},{"issue":"5","key":"9794_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/21541248.2016.1253528","volume":"9","author":"FM Vega","year":"2018","unstructured":"Vega FM, Ridley AJ (2018) The RhoB small GTPase in physiology and disease. Small GTPases 9(5):384\u2013393. https:\/\/doi.org\/10.1080\/21541248.2016.1253528","journal-title":"Small GTPases"},{"issue":"8","key":"9794_CR23","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1158\/1078-0432.CCR-03-0149","volume":"10","author":"J Mazieres","year":"2004","unstructured":"Mazieres J, Antonia T, Daste G, Muro-Cacho C, Berchery D, Tillement V et al (2004) Loss of RhoB expression in human lung cancer progression. Clin Cancer Res 10(8):2742\u20132750. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0149","journal-title":"Clin Cancer Res"},{"issue":"3","key":"9794_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ijc.22328","volume":"120","author":"N Sato","year":"2007","unstructured":"Sato N, Fukui T, Taniguchi T, Yokoyama T, Kondo M, Nagasaka T et al (2007) RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int J cancer 120(3):543\u2013551. https:\/\/doi.org\/10.1002\/ijc.22328","journal-title":"Int J cancer"},{"issue":"24","key":"9794_CR25","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1158\/1078-0432.CCR-14-0506","volume":"20","author":"O Calvayrac","year":"2014","unstructured":"Calvayrac O, Pradines A, Raymond-Letron I, Rouquette I, Bousquet E, Lauwers-Cances V et al (2014) RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for lepidic lung cancer. Clin Cancer Res 20(24):6541\u20136550. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0506","journal-title":"Clin Cancer Res"},{"issue":"15","key":"9794_CR26","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-08-4147","volume":"69","author":"E Bousquet","year":"2009","unstructured":"Bousquet E, Mazi\u00e8res J, Privat M, Rizzati V, Casanova A, Ledoux A et al (2009) Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1. Cancer Res 69(15):6092\u20136099. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4147","journal-title":"Cancer Res"},{"issue":"14","key":"9794_CR27","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/onc.2015.240","volume":"35","author":"E Bousquet","year":"2016","unstructured":"Bousquet E, Calvayrac O, Mazi\u00e8res J, Lajoie-Mazenc I, Boubekeur N, Favre G et al (2016) RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition. Oncogene 35(14):1760\u20131769. https:\/\/doi.org\/10.1038\/onc.2015.240","journal-title":"Oncogene"},{"key":"9794_CR28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12964-015-0085-y","volume":"13","author":"FM Vega","year":"2015","unstructured":"Vega FM, Thomas M, Reymond N, Ridley AJ (2015) The rho GTPase RhoB regulates cadherin expression and epithelial cell-cell interaction. Cell Commun Signal 13:6. https:\/\/doi.org\/10.1186\/s12964-015-0085-y","journal-title":"Cell Commun Signal"},{"key":"9794_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-14-95","volume":"14","author":"M Yamada","year":"2013","unstructured":"Yamada M, Kubo H, Ota C, Takahashi T, Tando Y, Suzuki T et al (2013) The increase of microRNA-21 during lung fibrosis and its contribution to epithelial-mesenchymal transition in pulmonary epithelial cells. Respir Res 14:1\u201313. http:\/\/respiratory-research.com\/content\/14\/1\/95","journal-title":"Respir Res"},{"issue":"6","key":"9794_CR30","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1159\/000445571","volume":"38","author":"L Lin","year":"2016","unstructured":"Lin L, Tu H, Wu L, Liu M, Jiang G (2016) MicroRNA-21 regulates non-small cell lung cancer cell invasion and chemo-sensitivity through SMAD7. Cell Physiol Biochem 38(6):2152\u20132162. https:\/\/doi.org\/10.1159\/000445571","journal-title":"Cell Physiol Biochem"},{"key":"9794_CR31","doi-asserted-by":"publisher","unstructured":"Su C, Cheng X, Li Y, Han Y, Song X, Yu D et al (2018) MiR-21 improves invasion and migration of drug\u2010resistant lung adenocarcinoma cancer cell and transformation of EMT through targeting HBP1. Cancer Med 62485\u20132503. https:\/\/doi.org\/10.1002\/cam4.1294","DOI":"10.1002\/cam4.1294"},{"issue":"2","key":"9794_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41419-017-0243-9","volume":"9","author":"L Shi","year":"2018","unstructured":"Shi L, Middleton J, Jeon Y-J, Magee P, Veneziano D, Lagan\u00e0 A et al (2018) KRAS induces lung tumorigenesis through microRNAs modulation. Cell Death Dis 9(2):219. https:\/\/doi.org\/10.1038\/s41419-017-0243-9","journal-title":"Cell Death Dis"},{"issue":"4","key":"9794_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3233\/CBM-201489","volume":"28","author":"G Wang","year":"2020","unstructured":"Wang G, Zhou Y, Chen W, Yang Y, Ye J, Ou H et al (2020) Mir-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Cancer Biomarkers 28(4):549\u2013559. https:\/\/doi.org\/10.3233\/CBM-201489","journal-title":"Cancer Biomarkers"},{"issue":"8","key":"9794_CR34","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2741\/4788","volume":"24","author":"L Dai","year":"2019","unstructured":"Dai L, Chen F, Zheng Y, Zhang D, Qian B, Ji H et al (2019) miR-21 regulates growth and EMT in lung cancer cells via PTEN\/Akt\/GSK3\u03b2 signaling. Front Biosci 24(8):1426\u20131439. https:\/\/doi.org\/10.2741\/4788","journal-title":"Front Biosci"},{"issue":"1\u20132","key":"9794_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1\u20132):55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"issue":"9","key":"9794_CR36","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41419-019-1898-1","volume":"10","author":"A Herreros-Pomares","year":"2019","unstructured":"Herreros-Pomares A, de-Maya-Girones JD, Calabuig-Fari\u00f1as S, Lucas R, Mart\u00ednez A, Pardo-S\u00e1nchez JM et al (2019) Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer. Cell Death Dis 10(9):660. https:\/\/doi.org\/10.1038\/s41419-019-1898-1","journal-title":"Cell Death Dis"},{"issue":"11\u201312","key":"9794_CR37","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","volume":"411","author":"J Zhang","year":"2010","unstructured":"Zhang J, Wang J, Zhao F, Liu Q, Jiang K, Yang G (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411(11\u201312):846\u2013852. https:\/\/doi.org\/10.1016\/j.cca.2010.02.074","journal-title":"Clin Chim Acta"},{"issue":"3","key":"9794_CR38","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3892\/etm.2018.6370","volume":"16","author":"S Li","year":"2018","unstructured":"Li S, Zeng X, Ma R, Wang L (2018) MicroRNA\u201321 promotes the proliferation, migration and invasion of non\u2013small cell lung cancer A549 cells by regulating autophagy activity via AMPK\/ULK1 signaling pathway. Exp Ther Med 16(3):2038\u20132045. https:\/\/doi.org\/10.3892\/etm.2018.6370","journal-title":"Exp Ther Med"},{"key":"9794_CR39","doi-asserted-by":"publisher","first-page":"116539","DOI":"10.1016\/j.lfs.2019.06.014","volume":"231","author":"J Zhong","year":"2019","unstructured":"Zhong J, Ren X, Chen Z, Zhang H, Zhou L, Yuan J et al (2019) Mir-21-5p promotes lung adenocarcinoma progression partially through targeting SET\/TAF-I\u03b1. Life Sci 231:116539. https:\/\/doi.org\/10.1016\/j.lfs.2019.06.014","journal-title":"Life Sci"},{"issue":"9","key":"9794_CR40","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/carcin\/bgr110","volume":"32","author":"JY Shih","year":"2011","unstructured":"Shih JY, Yang PC (2011) The EMT regulator slug and lung carcinogenesis. Carcinogenesis 32(9):1299\u20131304. https:\/\/doi.org\/10.1093\/carcin\/bgr110","journal-title":"Carcinogenesis"},{"issue":"22","key":"9794_CR41","doi-asserted-by":"publisher","first-page":"8070","DOI":"10.1158\/1078-0432.CCR-05-0687","volume":"11","author":"JY Shih","year":"2005","unstructured":"Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Yang PC (2005) Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin Cancer Res 11(22):8070\u20138078. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-0687","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9794_CR42","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1136\/thx.2009.121798","volume":"64","author":"A Jayachandran","year":"2009","unstructured":"Jayachandran A, K\u00f6nigshoff M, Yu H, Rupniewska E, Hecker M, Klepetko W, Eickelberg O (2009) SNAI transcription factors mediate epithelial\u2013mesenchymal transition in lung fibrosis. Thorax 64(12):1053\u20131061. https:\/\/doi.org\/10.1136\/thx.2009.121798","journal-title":"Thorax"},{"issue":"11","key":"9794_CR43","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.3390\/ijms21114002","volume":"21","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G (2020) Association of the epithelial\u2013mesenchymal transition (EMT) with cisplatin resistance. Int J Mol Sci 21(11):4002. https:\/\/doi.org\/10.3390\/ijms21114002","journal-title":"Int J Mol Sci"},{"key":"9794_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-12-91","volume":"12","author":"AM Haslehurst","year":"2012","unstructured":"Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Feilotter H (2012) EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12:1\u201310. https:\/\/doi.org\/10.1186\/1471-2407-12-91","journal-title":"BMC Cancer"},{"issue":"5","key":"9794_CR45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4161\/cbt.19073","volume":"13","author":"W Gao","year":"2012","unstructured":"Gao W, Lu X, Liu L, Xu J, Feng D, Shu Y (2012) MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer. Cancer Biol Ther 13(5):330\u2013340. https:\/\/doi.org\/10.4161\/cbt.19073","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"9794_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cancergen.2014.04.003","volume":"207","author":"L Xu","year":"2014","unstructured":"Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y et al (2014) Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer. Cancer Genet 207(5):214\u2013220. https:\/\/doi.org\/10.1016\/j.cancergen.2014.04.003","journal-title":"Cancer Genet"},{"issue":"1","key":"9794_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3892\/mmr.2014.2662","volume":"11","author":"Z Dong","year":"2015","unstructured":"Dong Z, Ren L, Lin L, Li J, Huang Y, Li J (2015) Effect of microRNA-21 on multidrug resistance reversal in A549\/DDP human lung cancer cells. Mol Med Rep 11(1):682\u2013690. https:\/\/doi.org\/10.3892\/mmr.2014.2662","journal-title":"Mol Med Rep"},{"issue":"8","key":"9794_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/cancers9080098","volume":"9","author":"E Forte","year":"2017","unstructured":"Forte E, Chimenti I, Rosa P, Angelini F, Pagano F, Calogero A, Messina E (2017) EMT\/MET at the crossroad of stemness, regeneration and oncogenesis: the Ying-Yang equilibrium recapitulated in cell spheroids. Cancers 9(8):98. https:\/\/doi.org\/10.3390\/cancers9080098","journal-title":"Cancers"},{"issue":"3","key":"9794_CR49","doi-asserted-by":"publisher","first-page":"zcaa014","DOI":"10.1093\/narcan\/zcaa014","volume":"2","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Wedler A, Breuer J, Gla\u00df M, Bley N, Lederer M et al (2020) Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice. NAR cancer 2(3):zcaa014. https:\/\/doi.org\/10.1093\/narcan\/zcaa014","journal-title":"NAR cancer"},{"issue":"6","key":"9794_CR50","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/ijms23062963","volume":"23","author":"AR Rama","year":"2022","unstructured":"Rama AR, Qui\u00f1onero F, Mesas C, Melguizo C, Prados J (2022) Synthetic circular miR-21 sponge as tool for lung cancer treatment. Int J Mol Sci 23(6):2963. https:\/\/doi.org\/10.3390\/ijms23062963","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9794_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/13813455.2020.1804406","volume":"129","author":"H Bai","year":"2023","unstructured":"Bai H, Li X, Wu S (2023) Up-regulation of long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical squamous cell carcinoma by sponging miR-21. Arch Physiol Biochem 129(1):143\u2013147. https:\/\/doi.org\/10.1080\/13813455.2020.1804406","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"9794_CR52","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/cancers15041291","volume":"15","author":"CZ Angel","year":"2023","unstructured":"Angel CZ, Stafford MYC, McNally CJ, Nesbitt H, McKenna DJ (2023) MiR-21 Is Induced by Hypoxia and Down-regulates RHOB in prostate Cancer. Cancers 15(4):1291. https:\/\/doi.org\/10.3390\/cancers15041291","journal-title":"Cancers"},{"key":"9794_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drup.2015.01.001","volume":"19","author":"D Mokady","year":"2015","unstructured":"Mokady D, Meiri D (2015) RhoGTPases\u2013a novel link between cytoskeleton organization and cisplatin resistance. Drug Resist Updat 19:22\u201332. https:\/\/doi.org\/10.1016\/j.drup.2015.01.001","journal-title":"Drug Resist Updat"},{"issue":"2","key":"9794_CR54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/genes9020067","volume":"9","author":"JA Ju","year":"2018","unstructured":"Ju JA, Gilkes DM (2018) RhoB: team oncogene or team tumor. Suppressor? Genes 9(2):67. https:\/\/doi.org\/10.3390\/genes9020067","journal-title":"Suppressor? Genes"},{"issue":"2","key":"9794_CR55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2010.02.025","volume":"295","author":"T \u010cimbora-Zovko","year":"2010","unstructured":"\u010cimbora-Zovko T, Fritz G, Mikac N, Osmak M (2010) Downregulation of RhoB GTPase confers resistance to cisplatin in human laryngeal carcinoma cells. Cancer Lett 295(2):182\u2013190. https:\/\/doi.org\/10.1016\/j.canlet.2010.02.025","journal-title":"Cancer Lett"},{"issue":"5","key":"9794_CR56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ijc.25445","volume":"128","author":"J Zhou","year":"2011","unstructured":"Zhou J, Zhu Y, Zhang G, Liu N, Sun L, Liu M et al (2011) A distinct role of RhoB in gastric cancer suppression. Int J Cancer 128(5):1057\u20131068. https:\/\/doi.org\/10.1002\/ijc.25445","journal-title":"Int J Cancer"},{"issue":"1","key":"9794_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/0008-5472.CAN-11-3055","volume":"73","author":"S Kazerounian","year":"2013","unstructured":"Kazerounian S, Gerald D, Huang M, Chin YR, Udayakumar D, Zheng N et al (2013) RhoB differentially controls akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res 73(1):50\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3055","journal-title":"Cancer Res"},{"issue":"2","key":"9794_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.molonc.2013.11.001","volume":"8","author":"D Luis-Ravelo","year":"2014","unstructured":"Luis-Ravelo D, Ant\u00f3n I, Zandueta C, Valencia K, Pajares M-J, Agorreta J et al (2014) RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner. Mol Oncol 8(2):196\u2013206. https:\/\/doi.org\/10.1016\/j.molonc.2013.11.001","journal-title":"Mol Oncol"},{"issue":"6","key":"9794_CR59","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/cancers11060818","volume":"11","author":"E Gutierrez","year":"2019","unstructured":"Gutierrez E, Cahatol I, Bailey CA, Lafargue A, Zhang N, Song Y, Zhang C (2019) Regulation of RhoB gene expression during tumorigenesis and aging process and its potential applications in these processes. Cancers 11(6):818. https:\/\/doi.org\/10.3390\/cancers11060818","journal-title":"Cancers"},{"key":"9794_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cellsig.2018.04.007","volume":"48","author":"M Livitsanou","year":"2018","unstructured":"Livitsanou M, Vasilaki E, Stournaras C, Kardassis D (2018) Modulation of TGF\u03b2\/Smad signaling by the small GTPase RhoB. Cell Signal 48:54\u201363. https:\/\/doi.org\/10.1016\/j.cellsig.2018.04.007","journal-title":"Cell Signal"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09794-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T22:52:39Z","timestamp":1738709559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09794-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9794"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09794-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"837"}}